Search research articles
Contact Us
Filters
Showing results (71-80 of 85) with videos related to
Page
of 9
Sort By:
The Australian and New Zealand Journal of Psychiatry
|
February 9, 2018
Clinical response to treatment in inpatients with depression correlates with changes in activity levels and psychomotor speed
Ian Re Averill, Marie Crowe, Chris M Frampton, et al.
Journal of Psychopharmacology (Oxford, England)
|
June 5, 2025
Six weeks open-label oral ketamine for patients with treatment-resistant depression, post-traumatic stress disorder, or obsessive-compulsive disorder
Ben Beaglehole, Paul Glue, Shona Neehoff, et al.
Bjpsych Open
|
October 1, 2025
Ketamine for treatment-resistant post-traumatic stress disorder: double-blind active-controlled randomised crossover study
Ben Beaglehole, Paul Glue, Shona Neehoff, et al.
The International Journal of Neuropsychopharmacology
|
July 6, 2026
Ketamine effects on EEG and their links to therapy differ across treatment-resistant major depression, post-traumatic stress disorder, and obsessive-compulsive disorder
Shabah M Shadli, Neda Nasrollahi, Calvin K Young, et al.
International Journal of Environmental Research and Public Health
|
June 10, 2023
The COVID Psychosocial Impacts Scale: A Reliable and Valid Tool to Examine the Psychosocial Impacts of the COVID-19 Pandemic
Sandila Tanveer, Philip J Schluter, Ben Beaglehole, et al.
BMJ Open
|
May 1, 2024
Protocol for a randomised controlled trial of ketamine versus ketamine and behavioural activation therapy for adults with treatment-resistant depression in the community
Ben Beaglehole, Richard Porter, Katie Douglas, et al.
BMC Psychiatry
|
February 3, 2019
Activation therapy for the treatment of inpatients with depression - protocol for a randomised control trial compared to treatment as usual
Ian R E Averill, Ben Beaglehole, Katie M Douglas, et al.
Bipolar Disorders
|
July 31, 2024
Cognitive predictors of response to interpersonal and social rhythm therapy in mood disorders
Samantha J Groves, Katie M Douglas, Marie T Crowe, et al.
Plos One
|
August 25, 2022
AcceSS and Equity in Transplantation (ASSET) New Zealand: Protocol for population-wide data linkage platform to investigate equity in access to kidney failure health services in New Zealand
Rachel B Cutting, Angela C Webster, Nicholas B Cross, et al.
Internal Medicine Journal
|
September 17, 2022
Symptom persistence and recovery among COVID-19 survivors during a limited outbreak in Canterbury, New Zealand: a prospective cohort study
Jeanette Cheung, Kim Nordmeier, Sarah Kelland, et al.
Page
of 9
Search research articles
Search
Showing results (71-80 of 85) with videos related to
Sort By:
Page
of 9
The Australian and New Zealand Journal of Psychiatry
|
February 9, 2018
Clinical response to treatment in inpatients with depression correlates with changes in activity levels and psychomotor speed
Ian Re Averill, Marie Crowe, Chris M Frampton, et al.
Journal of Psychopharmacology (Oxford, England)
|
June 5, 2025
Six weeks open-label oral ketamine for patients with treatment-resistant depression, post-traumatic stress disorder, or obsessive-compulsive disorder
Ben Beaglehole, Paul Glue, Shona Neehoff, et al.
Bjpsych Open
|
October 1, 2025
Ketamine for treatment-resistant post-traumatic stress disorder: double-blind active-controlled randomised crossover study
Ben Beaglehole, Paul Glue, Shona Neehoff, et al.
The International Journal of Neuropsychopharmacology
|
July 6, 2026
Ketamine effects on EEG and their links to therapy differ across treatment-resistant major depression, post-traumatic stress disorder, and obsessive-compulsive disorder
Shabah M Shadli, Neda Nasrollahi, Calvin K Young, et al.
International Journal of Environmental Research and Public Health
|
June 10, 2023
The COVID Psychosocial Impacts Scale: A Reliable and Valid Tool to Examine the Psychosocial Impacts of the COVID-19 Pandemic
Sandila Tanveer, Philip J Schluter, Ben Beaglehole, et al.
BMJ Open
|
May 1, 2024
Protocol for a randomised controlled trial of ketamine versus ketamine and behavioural activation therapy for adults with treatment-resistant depression in the community
Ben Beaglehole, Richard Porter, Katie Douglas, et al.
BMC Psychiatry
|
February 3, 2019
Activation therapy for the treatment of inpatients with depression - protocol for a randomised control trial compared to treatment as usual
Ian R E Averill, Ben Beaglehole, Katie M Douglas, et al.
Bipolar Disorders
|
July 31, 2024
Cognitive predictors of response to interpersonal and social rhythm therapy in mood disorders
Samantha J Groves, Katie M Douglas, Marie T Crowe, et al.
Plos One
|
August 25, 2022
AcceSS and Equity in Transplantation (ASSET) New Zealand: Protocol for population-wide data linkage platform to investigate equity in access to kidney failure health services in New Zealand
Rachel B Cutting, Angela C Webster, Nicholas B Cross, et al.
Internal Medicine Journal
|
September 17, 2022
Symptom persistence and recovery among COVID-19 survivors during a limited outbreak in Canterbury, New Zealand: a prospective cohort study
Jeanette Cheung, Kim Nordmeier, Sarah Kelland, et al.
Page
of 9